Rheumatology Advisor Contributing Writer

The benefits and effectiveness of the fourth dose of the COVID-19 vaccine were assessed among patients with autoimmune rheumatic disease.

Predictors of serious infection among patients with SLE were evaluated in a prospective study.

Researchers explored whether inactivated COVID-19 vaccine influences prothrombotic autoantibodies in antiphospholipid syndrome.

Using data from the COVID-19 Global Rheumatology Alliance, researchers studied the clinical characteristics of patients with rheumatic disease who developed SARS-CoV-2 breakthrough infections.

Study authors assessed the incidence, time-trends, and outcomes of serious infections in Sjögren syndrome.